Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
AXL protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of AXL mRNA | increases expression | 16788091
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of AXL mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of AXL mRNA | affects expression | 17562736
|
D000244 |
Adenosine Diphosphate |
AXL protein results in decreased susceptibility to Adenosine Diphosphate | decreases response to substance | 15733062
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AXL mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AXL mRNA | increases expression | 19150397
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AXL mRNA | affects cotreatment|decreases expression | 20360939
|
C110904 |
capecitabine |
AXL protein results in decreased susceptibility to capecitabine | decreases response to substance | 16734730
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of AXL mRNA | affects expression | 12734012
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of AXL protein | increases expression | 16799993
|
C014347 |
decitabine |
[decitabine results in decreased methylation of AXL gene] which results in increased expression of AXL | decreases methylation|increases expression | 18522535
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of AXL mRNA | increases expression | 16061661
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AXL mRNA | affects cotreatment|decreases expression | 20360939
|
C025034 |
doxifluridine |
AXL protein results in decreased susceptibility to doxifluridine | decreases response to substance | 16734730
|
D004317 |
Doxorubicin |
AXL protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D006861 |
Hydrogen Peroxide |
AXL protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 15123721
|
D006861 |
Hydrogen Peroxide |
GAS6 protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AXL protein] | increases phosphorylation|increases reaction | 15123721
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased phosphorylation of AXL protein | increases phosphorylation | 15123721
|
D006861 |
Hydrogen Peroxide |
Warfarin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of AXL protein] | decreases reaction|increases phosphorylation | 15123721
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of AXL mRNA | increases expression | 12634122
|
D010081 |
Oxazolone |
Oxazolone results in increased expression of AXL mRNA | increases expression | 11379042
|
D017239 |
Paclitaxel |
AXL protein results in increased susceptibility to Paclitaxel | increases response to substance | 16734730
|
D008926 |
Plicamycin |
Plicamycin results in decreased expression of AXL | decreases expression | 18522535
|
D012643 |
Selenium |
Selenium results in decreased expression of AXL mRNA | decreases expression | 19244175
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of AXL protein | increases expression | 12644472
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of AXL mRNA | increases expression | 12377990
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in decreased expression of AXL mRNA | decreases expression | 11379042
|
D014747 |
Vinblastine |
AXL protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of AXL mRNA | decreases expression | 19244175
|
D014859 |
Warfarin |
Warfarin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of AXL protein] | decreases reaction|increases phosphorylation | 15123721
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.62 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.33 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.75 | 17670903 12690470 15814532 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
4.54 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.54 | 17418594 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.23 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.23 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.29 | 18056438 16434500 17162532 19052882 17620307 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.29 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.32 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
3.43 | 20032816 16210060 15855793 19187332 11077013 3040596 12684321 7684630 16792590 18394133 10797510 10934080 11467998 8156442 12585506 15590890 12762349 170078 6091946 11742282 6091945 15590891 17015710 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.79 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.84 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
11.28 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.28 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.36 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.61 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
4.55 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
4.55 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.55 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.55 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.55 | 15939500 15634643 17426702 18382427 18695136 15993339 16264153 16826403 15567936 16595493 16935488 16322301 17983394 18234424 17369602 15692762 15136595 15994142 15668708 19526202 16096432 11325840 16115903 18628466 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
4.55 | 16273361 11325840 15136595 16115903 16244791 18323546 18223236 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.55 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
4.55 | 11921183 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
4.36 | 12507178 15590891 8156442 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.19 | 15700767 16097048 16227642 16011737 15673190 16124888 18705752 16192424 10355542 16050911 3786805 15721981 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
9.19 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.92 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
11.92 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.50 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.50 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
13.50 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
13.50 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
13.50 | 17978847 16328049 16288022 16698587 18393292 10672840 17173139 16569478 19335982 20727157 21159647 20214788 17138121 16878318 17761372 19208518 19052882 18978308 18210153 16502159 19822196 18506893 16779866 19701751 3581430 17055752 19171122 16935385 19539802 18788625 3084413 20514400 10737359 19919837 20524982 16540662 20935162 18665156 20007298 19107877 19383236 20101231 17162532 16681979 18691550 18785209 18056438 18494052 20432363 11831363 16830150 20084675 19394651 18971187 19519916 17428255 20512989 19418558 16807293 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.50 | 18059187 17876044 16234567 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
13.50 | 16313753 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.96 | 12023789 16685392 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.27 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.27 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
10.27 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
7.29 | 18337622 17066447 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.29 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.29 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.38 | 16612575 17519947 17928571 17007740 15811867 17131338 16952015 16242529 17382496 16364871 17974986 16455267 16278810 16269455 17924179 17351982 16651473 17308081 16731534 18627295 15792986 17329180 15476868 15505089 16109756 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.87 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.36 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.45 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.80 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.80 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.80 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
14.80 | 2727394 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.63 | 11061249 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.69 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.69 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.98 | 9022650 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.01 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D003092 |
Colitis |
|
Selenium |
3.56 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.30 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
8.11 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
8.11 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
8.11 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
8.11 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
8.11 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
8.11 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.46 | 12872399 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.59 | 17465463 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.61 | 20579077 20497562 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.41 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.41 | 19769572 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.56 | 14531868 18759878 11906362 8970840 12868966 11298694 8156756 2524372 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
6.56 | 12956900 15491423 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
14.65 | 2952479 3621924 |
MESH:D003877 |
Dermatitis, Contact |
|
Oxazolone |
14.65 | 12811023 15944321 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
14.65 | 17010967 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.54 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
4.30 | 11055810 12093613 15298345 7637645 18603373 19960420 11260395 1374869 8740154 6379147 17874149 19298542 16286809 17442507 15862027 12446591 19496084 16684804 12644472 2177838 18715473 15831366 12083368 19586609 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
6.14 | 18603373 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
6.14 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.88 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
6.88 | 19586609 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.88 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.50 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
marker/mechanism |
|
| 12644472 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
9.26 | 19682444 19960420 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
9.26 | 12644472 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.21 | 17662242 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.75 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
17.61 | 6679447 18692083 9328219 6482804 16192314 11289319 1440618 9022650 18648102 18289764 8291058 9653073 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
17.61 | 19164858 16781746 16485898 14725611 12594235 12958197 16177239 12705907 10774834 17906064 11834606 18071297 19085960 11461765 14986274 11421492 16393943 15968718 16227642 19416960 19420014 17522070 19370779 15619225 16081117 12540782 12392966 14550746 17562736 18713872 16109766 11739529 10915739 19923254 10663392 19739265 11287661 11743745 2444490 11529661 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
17.61 | 7179309 17522070 10915739 7120509 15027814 11566570 19085960 3786805 15968718 15998439 2869522 4309450 16177239 19336974 21278145 6623471 7440962 3732212 6884620 16227642 9327722 10092053 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.61 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
17.61 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
17.61 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.61 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
12.81 | 12231392 12649298 15033597 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
12.81 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.81 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.47 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.18 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 15322242 16714409 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.88 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.31 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.93 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
4.43 | 8156442 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.89 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.94 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.94 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
9.94 | 15464296 17638652 16785472 16481741 15173087 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
9.94 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
5.52 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.15 | 16045604 61145 15959796 16239168 12631006 17595544 12795759 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
7.15 | 21071580 20387270 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.79 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.36 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
7.85 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.85 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.44 | 16983495 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.48 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.74 | 12359135 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.20 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.82 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
12.18 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.18 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.18 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.10 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.23 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.17 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.17 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.59 | 16495754 16330681 18006777 16144979 16879835 16244371 17875725 12587719 16707910 17888722 18674790 14766674 16244372 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
7.59 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.79 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.79 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.48 | 17493413 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
9.82 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
9.82 | 18429757 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.50 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.50 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.67 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.62 | 16863852 16490937 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
11.35 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.35 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
11.35 | 18501091 18180244 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.74 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 8697196 15340226 16354765 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.52 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.30 | 16899240 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.71 | 15034207 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.40 | 11019492 10880147 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.82 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.86 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.65 | 12359135 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.05 | 17581917 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.51 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.51 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.19 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.19 | 16624496 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.39 | 10783313 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.79 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.91 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
22.19 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
22.19 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
22.19 | 12649298 19839026 18289764 12231392 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
22.19 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
22.19 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
22.19 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
15.56 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
15.56 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
15.56 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.78 | 6582329 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.56 | 11231351 |
MESH:D007938 |
Leukemia |
|
decitabine |
2.96 | 18980019 19235587 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.93 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.80 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.34 | 18704418 19387464 17679729 18206229 19010910 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.23 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
3.84 | 16766008 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.61 | 17353645 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.48 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.19 | 17157831 16239168 11903743 17174718 16943688 21278145 11408273 16221502 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.19 | 18665156 20032147 19638242 18407596 18522880 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.06 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.73 | 12546737 18418968 18339082 16097048 18187930 15893842 17922224 17900296 15996030 18205269 12958196 13678700 17631135 18279442 18210741 17721639 12898905 18263696 12649538 15650968 12632514 10355542 15362042 15959796 18412020 15052691 15931870 17565644 16248980 18156304 17714472 18429990 17557913 18317297 12632512 17976157 17805973 16027843 16192424 16116963 12741479 16011737 15730626 15876570 18395914 17640975 18251166 12445421 12586293 12667390 15818738 16033810 15338365 17525996 17761835 18006644 16638106 18420326 17708605 17823541 15123356 11481614 18376398 18054572 15673190 12666154 17766677 14512876 14748882 14716496 15057751 17869086 17698563 20821823 17481882 18395095 15925388 18705752 18472332 12445418 17944888 18472094 14724832 12609069 18277467 16136751 15370692 14620537 18166357 12389079 14716833 18481824 16015684 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.73 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.73 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.73 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.11 | 19460945 16610002 19014921 16611625 12969438 19784758 12587719 11587558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.11 | 15720792 16246199 15830285 16964402 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.11 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.94 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.75 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.75 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
6.88 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
6.88 | 19812893 18648771 12112319 19499222 12771043 19426721 19073162 18977376 19690152 21071580 21047994 20101389 19833225 19642983 18644402 19255062 20452335 19254457 20137499 20583210 18754104 2862719 20434301 21278145 16942905 15175105 18978307 19294768 20118626 19638242 20501860 21167192 15885732 19996281 19427195 19256749 19090486 20405173 2422723 9163691 19551842 20492335 10737359 19850985 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.88 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.14 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
17.14 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.14 | 18308698 3124819 9362446 19126423 16842330 18544905 19519916 18775883 16267830 18093689 19539802 18079962 19009564 17854601 18282651 21159647 17174075 19004024 18253720 18164116 17942915 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
17.14 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.14 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.03 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
6.29 | 17225452 6189445 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.29 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.29 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.29 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.29 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.19 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.19 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.35 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
8.35 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.34 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
5.71 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
5.71 | 15318939 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
9.38 | 17023156 16809738 16248763 16432458 15577323 18176117 18332650 18505091 11135225 12393984 12374674 17761969 12883367 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.38 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.38 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.38 | 12040289 12025231 16342250 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
9.38 | 15577320 16432458 17761969 16809738 16248763 18505091 12374674 15577323 18332650 18176117 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.55 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.34 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
9.74 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
9.74 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
9.74 | 15107826 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.66 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.29 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.56 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.06 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
7.06 | 14749477 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.25 | 19157545 16882708 19010910 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.86 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D009336 |
Necrosis |
|
Warfarin |
5.32 | 14723717 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
16.99 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
16.99 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
16.99 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
16.99 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
16.99 | 15867366 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
7.95 | 16374040 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
7.95 | 16773208 |
MESH:D009369 |
Neoplasms |
|
decitabine |
7.95 | 19116145 17925555 19470736 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
4.51 | 1670384 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.26 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.54 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.81 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.00 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.77 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.76 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.76 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.57 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.57 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.47 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.89 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.36 | 17378895 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.70 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
8.70 | 12585506 18394133 11077013 8156442 6091945 3040596 6091946 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.79 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.75 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.93 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
7.65 | 15464296 19769630 17225452 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.65 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
7.65 | 11161223 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.21 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
8.23 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.23 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.23 | 16540662 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.57 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.57 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.09 | 15464296 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.24 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.93 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.66 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
13.16 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
13.16 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.36 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.96 | 11399792 11222880 11896295 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.50 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.77 | 16729912 16888761 15897917 15749863 18437689 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.77 | 17172428 16729912 16356831 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.77 | 15084515 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
6.12 | 18376272 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
6.12 | 19300499 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
5.39 | 14606601 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.63 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.63 | 17922066 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.29 | 7692837 16940033 20219652 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
4.89 | 18447907 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.21 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.19 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
4.38 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
5.05 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
5.28 | 19075512 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.79 | 16767912 17710206 18313854 17203757 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.72 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.72 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.56 | 17846226 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.64 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.38 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
8.90 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
8.90 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.90 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.11 | 15464296 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
5.28 | 19075512 19050374 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.34 | 17203757 16767912 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.59 | 18396642 17522103 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.59 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.59 | 18506536 18396642 |
MESH:D020521 |
Stroke |
|
Vitamin E |
8.54 | 16517955 |
MESH:D020521 |
Stroke |
|
Warfarin |
8.54 | 19300499 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.58 | 16930453 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.42 | 15464296 17225452 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.93 | 18698879 16960144 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
5.38 | 17493413 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
4.93 | 11307788 17245631 11518727 15720958 17672075 19300499 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.71 | 7505956 6582329 6587162 3712494 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
15.71 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.71 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.71 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.24 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
11.24 | 17225452 15464296 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.24 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.24 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.01 | 16803524 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.68 | 17785578 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
10.56 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
10.56 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
5.64 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
6.14 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
5.30 | 15733061 14723717 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.00 | 17678736 17638931 17334414 16364871 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.49 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |